Sulfonylureas and cardiovascular mortality in diabetes: a class effect?
Wascher, T.C.
Circulation 97(14): 1427-1428
1998
ISSN/ISBN: 0009-7322 PMID: 9577959 Document Number: 485027
Document emailed within 1 workday
Related Documents
Chen, Y.; Wang, J.; An, Y.; Gong, Q.; He, Y.; Zhang, B.; Li, H.; Shuai, Y.; Tang, X.; Jiang, Y.; Hong, J.; Yang, W.; Hu, Y.; Li, G. 2015: Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study Zhonghua Nei Ke Za Zhi 54(1): 13-17Kirk, J.K.; Pearce, K.A.; Michielutte, R.; Summerson, J.H. 1999: Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes? Journal of Family Practice 48(11): 879-882
Tuomilehto, J.; Kuulasmaa, K.; Torppa, J. 1987: WHO MONICA Project: geographic variation in mortality from cardiovascular diseases. Baseline data on selected population characteristics and cardiovascular mortality World Health Statistics Quarterly. Rapport Trimestriel de Statistiques Sanitaires Mondiales 40(2): 171-184
Ford, E.S. 2005: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence Diabetes Care 28(7): 1769-1778
Brune, K.; Zacher, J. 2004: Cardiovascular risk: a class effect of coxibs? how to manage patients taking Vioxx? MMW Fortschritte der Medizin 146(42): 10; 12
Scheen, A.J. 2015: EMPA-REG OUTCOME: Empagliflozin reduces mortality in patients with type 2 diabetes at high cardiovascular risk Revue Medicale de Liege 70(11): 583-589
Miranda, V.P.; Rodrigues, M.J.O.; Gonçalves, F.R.; Nunes, J.é P.L. 2009: Effects of hypoglycemic agents on mortality and major cardiovascular outcomes in patients with type 2 diabetes mellitus: a narrative review [88 Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 28(10): 1099-1119
Sartor, G.; Melander, A.; Scherstén, B.; Wåhlin-Boll, E. 1980: Kinetics-effect relations of glipizide and other sulfonylureas Acta Endocrinologica. Supplementum 239: 3-5
Reis, S.E.; Feldman, A.H. 1997: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery New England Journal of Medicine 336(20): 1453; Author Reply 1453-1454
Matsumoto, M.; Kato, S.; Yokoyama, H.; Ishii, H. 1997: Effect of alcohol on patients with diabetes, hypertension or cardiovascular disease Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 597-603
Nossent, H. 2000: Risk of cardiovascular events and effect on mortality in patients with rheumatoid arthritis Journal of Rheumatology 27(9): 2282-2283
Deleers, M.; Grognet, P.; Mahy, M.; Brasseur, R.; Malaisse, W.J. 1983: Synergistic effect of hypoglycemic sulfonylureas and negative phospholipids on calcium transport: ionic and conformational aspects Research Communications in Chemical Pathology and Pharmacology 41(3): 407-424
Tomov, I. 1985: Effect of antihypertensive drug treatment on the incidence of cardiovascular morbidity and mortality in mild arterial hypertension Vutreshni Bolesti 24(6): 39-47
Päivänsalo, M.J.; Merikanto, J.; Savolainen, M.J.; Lilja, M.; Rantala, A.O.; Kauma, H.; Reunanen, A.; Kesäniemi, Y.A.; Suramo, I. 1998: Effect of hypertension, diabetes and other cardiovascular risk factors on kidney size in middle-aged adults Clinical Nephrology 50(3): 161-168
1991: Relation of cholesterol level to cardiovascular mortality among men with and without preexisting cardiovascular disease New England Journal of Medicine 324(1): 60-61
Liakishev, A.A. 2004: Effect of Long-Acting Nifedipine on Mortality and Cardiovascular Morbidity in Patients with Stable Angina Requiring Treatment. Results of the ACTION Study Kardiologiia 44(12): 75
Jarrett, R.J. 2001: Glycaemia and vascular effects of type 2 diabetes. Relation between diabetes and hyperglycaemia and cardiovascular disease has not been resolved Bmj 322(7296): 1246-1247
Schneider, H.; Ziegelasch, H.J. 1981: The cardiovascular risk profile in patients with disorders of glucose tolerance (borderline diabetes) dependent on the heredity of the diabetes Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 36(7): 241-243
Dickman, P.W.; Auvinen, A.; Voutilainen, E.T.; Hakulinen, T. 1998: Measuring social class differences in cancer patient survival: is it necessary to control for social class differences in general population mortality? a Finnish population-based study Journal of Epidemiology and Community Health 52(11): 727-734
Kleber, M.E.; Winkler, K.; Wolfert, R.L.; Delgado, G. de Moissl; Grammer, T.B.; Dietz, S.; Winkelmann, B.R.; Boehm, B.O.; Winfried März 2011: Lipoprotein Associated Phospholipase A2 Concentration Predicts Total and Cardiovascular Mortality Independently of Established Risk Factors (The Ludwigshafen Risk and Cardiovascular Health Study) Clinical Laboratory 57(9-10): 659-667